- TRADE NAME: AdreView (GE Healthcare)
- INDICATIONS: Detection of primary or metastatic pheochromocytoma or neuroblastoma as an adjunct to other diagnostic tests
- SYNONYM: metaiodobenzylguanidine; MIBG
- CLASS: Radiopharmaceutical, diagnostic agent
- HALF-LIFE: 13 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amitriptyline, Amoxapine, Citalopram, Cocaine, Duloxetine, Ephedrine, Formoterol, Formoterol, Imipramine, Labetalol, Levalbuterol, Lisdexamfetamine, Phenylephrine, Phenylpropanolamine, Pseudoephedrine, Reserpine, Salmeterol, SSRIs, Terbutaline
Please login to view the rest of this drug profile.
Page last updated 07/31/2023